Michael Anstey

Investment Director

Dr Michael Anstey is an Investment Director specialising in healthcare investments.

Before joining CIC, Michael was a Principal in the Healthcare Practice Area at The Boston Consulting Group’s (BCG) Toronto office. He has experience in advising multinational healthcare businesses across North America, Europe, India, and Japan on a broad range of topics, including corporate strategy, sales and marketing, new launches, R&D and medical strategy, and M&A. Michael is also a co-founder of Proteorex Therapeutics Inc, a Canadian biotechnology company developing small molecule drugs that target protein-protein interactions implicated in disease.

Prior to BCG, Michael worked in venture capital, where he focused on investing in early stage healthcare and life science businesses.

He earned his DPhil in Zoology in the field of neurobiology, jointly supervised by the Universities of Cambridge and Oxford.

Michael sits on the board of Bicycle Therapeutics.